Article info

Download PDFPDF
Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital

Authors

  1. Correspondence to Dr Muge Cevik, Specialist Virology Centre, Royal Infirmary of Edinburgh, Little France, Edinburgh EH16 4SA, UK; muge.cevik{at}nhs.net
View Full Text

Citation

Cevik M, McGann H
Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital

Publication history

  • Received June 15, 2018
  • Accepted June 21, 2018
  • First published July 20, 2018.
Online issue publication 
August 20, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.